Risk of First Infection-Related Hospitalization Higher With HHD
Hemodialysis patients who have fistula are 24% more likely to experience a first infection-related hospitalization if they dialyze at home rather than in a dialysis center.
|The following article is part of conference coverage from Kidney Week 2017 in New Orleans hosted by the American Society of Nephrology. Renal & Urology News staff will be reporting live on medical studies conducted by nephrologists and other specialists who are tops in their field in acute kidney injury, chronic kidney disease, dialysis, transplantation, and more. Check back for the latest news from Kidney Week 2017.|
NEW ORLEANS—Hemodialysis (HD) patients who have a fistula for vascular access are at higher risk of a first infection-related hospitalization (IH) if they dialyze at home rather than in a dialysis center, according to study findings presented at the American Society of Nephrology's Kidney Week 2017 meeting.
Eric D. Weinhandl, PhD, and Allan J. Collins, MD, both of NxStage Medical, Inc., in Lawrence, Massachusetts, and the University of Minnesota in Minneapolis, analyzed data from 4304 home HD (HHD) patients and 46,988 in-center HD (IHD) patients identified using the U.S. Renal Data System database. HHD patients had a 24% increased risk of a first IH in adjusted analyses, the investigators reported. HHD patients had a similar or slightly lower risk of recurrent IH.
In both dialysis settings, each additional IH discharge increased the risk of another IH, according to the investigators.
“Less time to first IH in HHD patients prematurely sets in motion the cycle of increasing risk, ultimately manifesting as a higher IH rate on HHD versus IHD,” the authors concluded. “Attention should be devoted to prevention of the first infection on HHD.”
|Visit Renal & Urology News' conference section for continuous coverage from Kidney Week 2017.|
Weinhandl ED, Collins AJ. Fist and recurrent hospitalized infections in home and in-center hemodialysis patients. Data presented in poster format at Kidney Week 2017 in New Orleans (Oct. 31 to Nov. 5). Abstract TH-PO902.